tiprankstipranks
Trending News
More News >
BioAtla (BCAB)
NASDAQ:BCAB
US Market

BioAtla (BCAB) Financial Statements

Compare
717 Followers

BioAtla Financial Overview

BioAtla's market cap is currently $20.01M. The company's EPS TTM is $-0.27; its P/E ratio is -0.28; BioAtla is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 11.00M$ 0.00$ 0.00$ 250.00K$ 429.00K
Gross Profit$ 10.07M$ -1.22M$ -1.20M$ 250.00K$ -19.50M
Operating Income$ -73.94M$ -129.69M$ -108.14M$ -96.44M$ -30.10M
EBITDA$ -73.02M$ -122.24M$ -105.28M$ -94.07M$ -33.46M
Net Income$ -69.78M$ -123.46M$ -105.28M$ -95.40M$ -35.85M
Balance Sheet
Cash & Short-Term Investments$ 49.05M$ 111.47M$ 215.51M$ 244.98M$ 238.60M
Total Assets$ 52.42M$ 119.66M$ 225.74M$ 254.42M$ 244.94M
Total Debt$ 836.00K$ 2.46M$ 3.98M$ 5.37M$ 682.00K
Net Debt$ -48.21M$ -109.01M$ -211.53M$ -239.61M$ -237.92M
Total Liabilities$ 38.16M$ 48.99M$ 45.40M$ 43.60M$ 34.96M
Stockholders' Equity$ 14.27M$ 70.67M$ 180.34M$ 210.82M$ 209.97M
Cash Flow
Free Cash Flow$ -71.94M$ -104.11M$ -90.69M$ -63.14M$ -36.92M
Operating Cash Flow$ -71.94M$ -104.02M$ -90.42M$ -62.21M$ -36.33M
Investing Cash Flow$ 0.00$ -98.00K$ -265.00K$ -924.00K$ -590.00K
Financing Cash Flow$ 9.51M$ 77.00K$ 61.21M$ 69.51M$ 271.82M
Currency in USD

BioAtla Earnings and Revenue History

BioAtla Debt to Assets

BioAtla Cash Flow

BioAtla Forecast EPS vs Actual EPS